LeMaitre Vascular Cash Flow from Operating Activities 2010-2025 | LMAT

LeMaitre Vascular cash flow from operating activities from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.

LeMaitre Vascular Cash Flow from Operating Activities 2010-2025 | LMAT

LeMaitre Vascular cash flow from operating activities from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$232.4B
Boston Scientific (BSX)$153.7B
Stryker (SYK)$150.7B
EssilorLuxottica (ESLOY)$135.2B
Medtronic (MDT)$114.7B
Lonza Group Ag (LZAGY)$51.4B
Haleon (HLN)$45.4B
ResMed (RMD)$37.8B
Agilent Technologies (A)$35.3B
GE HealthCare Technologies (GEHC)$35B
Terumo (TRUMY)$24.7B
Koninklijke Philips (PHG)$23.7B
Insulet (PODD)$20.9B
Zimmer Biomet Holdings (ZBH)$18.8B
Baxter (BAX)$15.2B
Smith & Nephew SNATS (SNN)$13.6B
Demant (WILYY)$9B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$7.1B
Lantheus Holdings (LNTH)$5.8B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.8B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.4B
QuidelOrtho (QDEL)$2.1B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.4B